FibroBiologics, Inc. Entity Listing, Par Value Per Share
FibroBiologics, Inc. (FBLG) reported Entity Listing, Par Value Per Share of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-07-31
- FibroBiologics, Inc. entity listing, par value per share for the quarter ending 2026-03-31 was $0.00, a 0.00% change year-over-year.
- FibroBiologics, Inc. entity listing, par value per share for the quarter ending 2025-03-31 was $0.00.
- FibroBiologics, Inc. entity listing, par value per share for fiscal 2025 was $0.00, a 0.00% change from fiscal 2024.
- FibroBiologics, Inc. entity listing, par value per share for fiscal 2024 was $0.00.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month | Entity Listing, Par Value Per Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-31 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | $0.00 10-K/A · filed 2026-03-13 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-10-31 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |